These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 29136743)

  • 21. [Genetic Subtypes and Pretreatment Drug Resistance in the Newly Reported Human Immunodeficiency Virus-Infected Men Aged≥50 Years Old in Guangxi].
    Fang NY; Wei WC; Li JJ; Cen P; Feng XX; Yang D; Tang KL; Liang SJ; Shao YL; Lu HX; Jiang H; Meng Q; Liu SF; Zhu QY; Chen HH; Lan GH; Yang SX; Zhou LF; Mo JL; Ge XM
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Jun; 45(3):399-404. PubMed ID: 37407525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Research on the treatment effects and drug resistances of long-term second-line antiretroviral therapy among HIV-infected patients from Henan Province in China.
    Chen J; Zhang M; Shang M; Yang W; Wang Z; Shang H
    BMC Infect Dis; 2018 Nov; 18(1):571. PubMed ID: 30442114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Drug-resistance characteristics of CRF01_AE and CRF07_BC subtypes of HIV-1 strains in Sichuan province].
    Yuan D; Su L; Liu H; Yu H; Yang H; Ye L; Wei D; Pei X; Liang S
    Zhonghua Yu Fang Yi Xue Za Zhi; 2015 Oct; 49(10):901-6. PubMed ID: 26813724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High resistance to reverse transcriptase inhibitors among persons infected with human immunodeficiency virus type 1 subtype circulating recombinant form 02_AG in Ghana and on antiretroviral therapy.
    Deletsu SD; Maina EK; Quaye O; Ampofo WK; Awandare GA; Bonney EY
    Medicine (Baltimore); 2020 Feb; 99(7):e18777. PubMed ID: 32049783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of HIV-1 drug resistance among patients failing first-line antiretroviral therapy in Ethiopia.
    Getaneh Y; He Q; Rashid A; Kassa D; Kang L; Yi F; Liao L; Shao Y
    J Glob Antimicrob Resist; 2022 Sep; 30():418-427. PubMed ID: 35917929
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Investigation of HIV-1 primary drug resistance mutations in antiretroviral therapy-naive cases].
    Yalçınkaya T; Köse S
    Mikrobiyol Bul; 2014 Oct; 48(4):585-95. PubMed ID: 25492654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of HIV-1 molecular epidemiology and transmitted drug-resistance in newly diagnosed HIV-infected patients in Sichuan, China.
    Zhou C; Liang S; Li Y; Zhang Y; Li L; Ye L; Yuan D; Su L
    BMC Infect Dis; 2022 Jul; 22(1):602. PubMed ID: 35799101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Etravirine and rilpivirine resistance in HIV-1 subtype CRF01_AE-infected adults failing non-nucleoside reverse transcriptase inhibitor-based regimens.
    Bunupuradah T; Ananworanich J; Chetchotisakd P; Kantipong P; Jirajariyavej S; Sirivichayakul S; Munsakul W; Prasithsirikul W; Sungkanuparph S; Bowonwattanuwong C; Klinbuayaem V; Petoumenos K; Hirschel B; Bhakeecheep S; Ruxrungtham K
    Antivir Ther; 2011; 16(7):1113-21. PubMed ID: 22024527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV-1 Drug Resistance, Distribution of Subtypes, and Drug Resistance-Associated Mutations in Virologic Failure Individuals in Chengdu, Southwest China, 2014-2016.
    Chen J; Liu Y; Liu S; Yuan D; Su L; Ye L; Gong F; Gao Y; Baloch S; Pei X
    Biomed Res Int; 2020; 2020():5894124. PubMed ID: 32280691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV-1 drug resistance genotyping from antiretroviral therapy (ART) naïve and first-line treatment failures in Djiboutian patients.
    Elmi Abar A; Jlizi A; Darar HY; Kacem MA; Slim A
    Diagn Pathol; 2012 Oct; 7():138. PubMed ID: 23044036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Study on genotypic resistance mutations to antiretroviral drugs on HIV strains of treated and treatment-naive HIV-1 infectious patients in Hubei province].
    Wang XQ; Tong X; Tang H; Liu PP; Zhang W; Yang RG
    Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Nov; 28(11):1112-5. PubMed ID: 18396668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [HIV-1 drug-resistance profiles of treated AIDS patients in Liaoning: genetic characteristics and prevalence].
    Wu SH; Lu CM; Jiang FX; Ma N; E S; Pan S
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Dec; 30(12):1273-6. PubMed ID: 20193313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and determinants of virological failure, genetic diversity and drug resistance among people living with HIV in a minority area in China: a population-based study.
    Yuan D; Liu M; Jia P; Li Y; Huang Y; Ye L; Api L; Chen M; Yao L; Wang Z; Liu H; Liang S; Yang S
    BMC Infect Dis; 2020 Jun; 20(1):443. PubMed ID: 32576136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prevalence and determinants of drug-resistance-associated mutations in the HIV-1-infected MSM population of Henan Province in China.
    Hou LJ; Wang HW; Duan SP; Zhuo Y; Zhou YC; Wu HJ; Shen BS
    Arch Virol; 2015 Aug; 160(8):2051-61. PubMed ID: 26077516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV-1 Subtype Diversity and Factors Affecting Drug Resistance among Patients with Virologic Failure in Antiretroviral Therapy in Hainan Province, China, 2014-2020.
    Yu E; Xu YJ; Li M; Yang Y; Liang HY; Zhong SM; Qin C; Lan YN; Li DW; Yu JP; Pang Y; Qin XQ; Liang H; Zhu KK; Ye L; Liang BY
    Biomed Environ Sci; 2023 Sep; 36(9):800-813. PubMed ID: 37803893
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prevalence of resistance to antiretroviral drugs in Spain].
    Larrú Martínez B; de José MI; Bellón JM; Gurbindo MD; León JA; Ciria L; Ramos JT; Mellado MJ; Pocheville I; Jiménez JL; Muñoz-Fernández M
    An Pediatr (Barc); 2007 Aug; 67(2):104-8. PubMed ID: 17692254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low prevalence of the transmitted HIV-1 drug resistance among newly diagnosed HIV-1 individuals in Jiangsu Province, China during 2009-2011.
    Guo H; Xu X; Hu H; Zhou Y; Yang H; Qiu T; Fu G; Huan X
    BMC Public Health; 2015 Feb; 15():120. PubMed ID: 25879488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cross-sectional study of virological failure and multinucleoside reverse transcriptase inhibitor resistance at 12 months of antiretroviral therapy in Western India.
    Karade SK; Ghate MV; Chaturbhuj DN; Kadam DB; Shankar S; Gaikwad N; Gurav S; Joshi R; Sane SS; Kulkarni SS; Kurle SN; Paranjape RS; Rewari BB; Gangakhedkar RR
    Medicine (Baltimore); 2016 Sep; 95(37):e4886. PubMed ID: 27631260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Mutation of drug resistant gene in HIV/AIDS patients with antiretroviral therapy in Shandong province in 2011].
    Sun XG; Lin B; Su SL; Lin L; Tao XR; Qian YS; Kang DM
    Zhonghua Yu Fang Yi Xue Za Zhi; 2012 Nov; 46(11):982-6. PubMed ID: 23363916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV-1 drug resistance mutations in children after failure of first-line nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy.
    Puthanakit T; Jourdain G; Hongsiriwon S; Suntarattiwong P; Chokephaibulkit K; Sirisanthana V; Kosalaraksa P; Petdachai W; Hansudewechakul R; Siangphoe U; Suwanlerk T; Ananworanich J;
    HIV Med; 2010 Oct; 11(9):565-72. PubMed ID: 20345882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.